How to Give: Impacting Cancer Care in the Middle East
The Israeli Fellowship in Radiation Oncology
Radiation therapy plays a major role in the treatment of cancer. Most cancer patients will undergo this type of treatment during the course of their illness. For every patient cured by drugs, four are cured by radiation therapy.
In Israel, training in radiation therapy is but a small part of a medical oncology (i.e., chemotherapy) program. Not surprisingly, there are few highly trained radiation oncology specialists in Israel. As a consequence, Israeli radiation oncologists routinely treat up to four to five times more patients than their American counterparts — clearly an unmanageable load.
The University of Michigan Israeli Fellowship Program, initiated in 1993, has invited Israeli physicians to study and work beside the Department of Radiation Oncology’s world-class physician/scientists, gaining critical experience in ultra-specialized radiation therapy, clinical protocols, laboratory research and academic collaboration.
The current Israeli Fellow is Orit Gutfeld, M.D., of Hadassah University Hospital in Jerusalem. Funds are now being raised to support Dr. Khaled Thabet's training in 2010, for eventual practice at Augusta Victoria Hospital in East Jerusalem. Augusta Victoria Hospital treats a majority of cancer patients from the West Bank.
This past spring, Dr. Mohamed Aboziada, a radiation oncologist from South Egypt Cancer Institute in Assiut, came to U-M to train with Dr. Avraham Eisbruch in the Department of Radiation. During his month-long stay, he focused on learning about the treatment of head and neck cancers. His visit was supported by the International Union Against Cancer.
To make a secured gift online, please visit Michigan Online Giving.
Associate Director of Development